WebNov 18, 2024 · Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic ... DEFINITY RT is a modified formulation of DEFINITY that allows both … WebWhen you visit one of our hospitals and facilities, we want you to feel at ease and excited for the next step in your wellness adventure. You do everything to protect your children. So …
Lantheus Holdings, Inc. Announces FDA Approval of …
WebSep 28, 2024 · January 7, 2024 updated by: Lantheus Medical Imaging. A Phase III, Open-Label, Multicenter Trial to Evaluate Ejection Fraction, End-Diastolic and End-Systolic Volumes, by Unenhanced and DEFINITY®-Enhanced 2D-Echo and Magnetic Resonance Imaging. This is a Phase 3, prospective, open-label, multicenter study to evaluate Left … WebDEFINITY® [package insert]. N. Billerica, MA: Lantheus Medical Imaging, Inc. Kitzman DW, Goldman ME, Gillam LD, Cohen JL, Aurigemma GP, Gottdiener JS. Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol. 2000;86 (6):669-674. fro28
Lantheus Announces the Approval of DEFINITY® (Perflutren Lipid ...
WebWe own or have the rights to various trademarks, service marks and trade names, including, among others, the following: DEFINITY ®, TechneLite ®, Cardiolite ®, Neurolite ®, … WebCustomer Service Reference: For customer orders, please call Lantheus Medical Imaging Customer Services at 1-800-299-3431. Caution: The only intended use of Vialmix® is for the activation of Definity Vial for (Perflutren Lipid Microsphere) Injectable Suspension. WebNov 28, 2024 · 1 DEFINITY ® (Package Insert), North Billerica, MA, Lantheus Medical Imaging, Inc. 2 Data on file, Lantheus Medical Imaging, Inc. 3 DRG Echo Monthly Monitor 2024. Contacts: Mark Kinarney Vice President, Investor Relations 978-671-8842 [email protected]. Melissa Downs Senior Director, Corporate Communications 646-975 … fd40-11a